Back to Journals » Drug, Healthcare and Patient Safety » Volume 11

Drug, Healthcare and Patient Safety


Archive: Volume 11, 2019

Selexipag in the management of pulmonary arterial hypertension: an update

Coghlan JG, Picken C, Clapp LH

Drug, Healthcare and Patient Safety 2019, 11:55-64

Published Date: 6 August 2019

Critical evaluation of the validity of drug promotion materials in Ethiopia

Hailu HG, Gobezie MY, Yesuf TA, Workneh BD

Drug, Healthcare and Patient Safety 2019, 11:47-54

Published Date: 24 July 2019

Utilization of over-the-counter analgesics in two private medical insurance schemes in South Africa

Padayachee N, Rothberg AD, Truter I, Butkow N

Drug, Healthcare and Patient Safety 2019, 11:37-45

Published Date: 17 July 2019

Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines

Mahi-Birjand M, Ziaee M, Bijari B, Khalvati R, Abedini MR, Golboei Mousavi H, Ziaee A

Drug, Healthcare and Patient Safety 2019, 11:29-35

Published Date: 8 April 2019

Adherence to risk management guidelines for drugs which cause vitamin D deficiency – big data from the Swedish health system

Nordqvist O, Lönnbom Svensson U, Brudin L, Wanby P, Carlsson M

Drug, Healthcare and Patient Safety 2019, 11:19-28

Published Date: 22 March 2019

Evaluation to improve the quality of medication preparation and administration in pediatric and adult intensive care units

Hermanspann T, van der Linden E, Schoberer M, Fitzner C, Orlikowsky T, Marx G, Eisert A

Drug, Healthcare and Patient Safety 2019, 11:11-18

Published Date: 19 March 2019

Pattern of medication use in geriatric patients at primary healthcare facilities in Karawang, Indonesia

Abdulah R, Insani WN, Putri NE, Purba HP, Destiani DP, Barliana MI

Drug, Healthcare and Patient Safety 2019, 11:1-5

Published Date: 8 February 2019